Commercial insulin preparations differ in a number of ways, such as differences in the recombinant DNA production techniques, amino acid sequence, concentration, solubility, and the time of onset and duration of their biologic action
Two randomized phase 3 studies of aducanumab in early Alzheimer's disease
These usually contain an FDA-approved ingredient called dihydroxyacetone (DHA)
On the same line of evidence, supplementation of cells of neuronal origin with a membrane permeable GSH derivative (GSH60) protects them from NO neurotoxicity (Hu et al., 2012)
Clinical, biochemical, and molecular characterization of patients with glutathione synthetase deficiency
(3) suppresses appetite in the brain